Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).

Basit Öğe Kaydı
dc.authoridRimassa, Lorenza/0000-0001-9957-3615
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authorwosidzagonel, vittorina/F-4226-2014
dc.authorwosidRimassa, Lorenza/N-4884-2016
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.contributor.authorRimassa, Lorenza
dc.contributor.authorCicin, Irfan
dc.contributor.authorBlanc, Jean-Frederic
dc.contributor.authorKlumpen, Heinz Josef
dc.contributor.authorZagonel, Vittorina
dc.contributor.authorTran, Albert
dc.contributor.authorKim, Stefano Chong Hun
dc.date.accessioned2024-06-12T11:22:27Z
dc.date.available2024-06-12T11:22:27Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1200/JCO.2018.36.15_suppl.4090
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2018.36.15_suppl.4090
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25935
dc.identifier.volume36en_US
dc.identifier.wosWOS:000442916001666en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleOutcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC).en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu